Biodesix: 216 of the Inc500 for 2015

“Biodesix discovers and commercializes cancer tests that help patients and their doctors make more informed decisions about treatment based on a patient’s unique molecular profile….” Read more at inc.com Subscribe to the Blog Google+ Twitter...

Study: better NSCLC outcomes with proteomic test

The VeriStrat proteomic test, when used to help guide treatment of patients with advanced non-small cell lung cancer, improves overall survival and decreases medical costs in the U.S. payer system, said a study published recently in the journal Lung Cancer. “Systems...